Table 5. Adverse Effects.
| Adverse effects | Vitamin D status |
All patients (N = 291) | P-value | ||
|---|---|---|---|---|---|
| Deficiency (N = 113) | Insufficiency (N = 105) | Normal (N = 73) | |||
| Fatigue | 32 (28.3%) | 26 (24.8%) | 23 (31.5%) | 81 (27.8%) | 0.608 |
| Insomnia | 3 (2.7%) | 0 | 0 | 3 (1%) | 0.092 |
| Headache | 5 (4.4%) | 6 (5.7%) | 4 (5.5%) | 15 (5.2%) | 0.902 |
| Nausea | 5 (4.4%) | 5 (4.8%) | 4 (5.5%) | 14 (4.8%) | 0.947 |
| Diarrhea | 1 (0.9%) | 0 | 0 | 1 (0.3%) | 0.454 |
| Constipation | 0 | 1 (1%) | 1 (1.4%) | 2 (0.7%) | 0.499 |
| Abdominal pain | 3 (2.7%) | 0 | 1 (1.4%) | 4 (1.4%) | 0.243 |
| Skin rash | 8 (7.1%) | 4 (3.8%) | 2 (2.7%) | 14 (4.8%) | 0.336 |
| Arthralgia | 4 (3.5%) | 4 (3.8%) | 4 (5.5%) | 12 (4.1%) | 0.793 |
| Anemia | 18 (15.9%) | 11 (10.5%) | 12 (16.4%) | 41 (14.1%) | 0.410 |
Data presented as number (percent).